You have 9 free searches left this month | for more free features.

Condition

Acute Myeloid Leukemia (AML) (1)

Advanced Cancer (1)

Advanced Malignancies (1)

Myelodysplastic Syndrome (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

Astellas Pharma Global Development, Inc. (2)

Collaborator

Intervention

asp7517 (2)

pembrolizumab (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

ASP7517

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Malignancies, Advanced Cancer Trial in United States (ASP7517, Pembrolizumab)

Recruiting

Advanced Malignancies
Advanced Cancer

ASP7517
Pembrolizumab

Atlanta, Georgia
+3 more

Aug 2, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome Trial in Japan, United States (ASP7517)

Active, not recruiting

Acute Myeloid Leukemia (AML)
Myelodysplastic Syndrome

ASP7517

Duarte, California
+15 more

Jan 19, 2023